Strides Pharma Science Ltd approves NCD issue to raise Rs. 150 crores

The duly authorized Committee of Directors of Strides Pharma Science Limited at its meeting held today i.e. Monday, July 25, 2022 considered and approved offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, Non-Convertible Debentures (NCDs) of face value Rs. 10,00,000/- each aggregating up to Rs. 150 Crores.

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 334.85 as compared to the previous close of Rs. 339.45. The total number of shares traded during the day was 13359 in over 1040 trades.

The stock hit an intraday high of Rs. 341.35 and intraday low of 333.00. The net turnover during the day was Rs. 4486810.00.

Source : Equity Bulls

Keywords

StridesPharmaScience INE939A01011 NCDs FundRaising